BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
Alizyme Reports Positive Data From Renzapride Phase IIb Trial
Oct. 1, 2003
By
Nuala Moran
UK, Even After Pro-GM Campaign, Registers Concerns For GM Crops
Oct. 1, 2003
By
Nuala Moran
UK, Even After Pro-GM Campaign, Registers Concerns For GM Crops
Oct. 1, 2003
By
Nuala Moran
Alizyme Reports Positive Data From Renzapride Phase IIb Trial
Oct. 1, 2003
By
Nuala Moran
MMI Group Pushes Ahead With Work In Ruthenium Compounds
Sep. 24, 2003
By
Nuala Moran
Alizyme Reports Strong Phase II Results On Drug For Weight Loss
Sep. 24, 2003
By
Nuala Moran
Alizyme Reports Strong Phase II Results On Drug For Weight Loss
Sep. 24, 2003
By
Nuala Moran
Genzyme Invests $37.7M In CAT As Companies Restructure Pact
Sep. 24, 2003
By
Nuala Moran
MMI Group Pushes Ahead With Work In Ruthenium Compounds
Sep. 24, 2003
By
Nuala Moran
Genzyme Invests $37.7M In CAT As Companies Restructure Pact
Sep. 23, 2003
By
Nuala Moran
Previous
1
2
…
459
460
461
462
463
464
465
466
467
…
527
528
Next